An FDA-cleared predictive analytic tool for hemodynamic instability may soon leverage its success in critical care to the ...

A machine learning model may help predict mortality for hospitalized patients with cirrhosis at the time of admission, ...

In this Healio Video Perspective from the ARVO meeting, Osamah J. Saeedi, MD, discusses a study that looked at the impact of ...

Declining physical activity in the years leading up to a heart-related event was frequent, with even steeper declines ...

Four previously tested AI diagnostic algorithms for skin cancer demonstrated lower sensitivity and specificity when tested on ...

The FDA accepted a resubmitted new drug application for reproxalap, a first-in-class investigational topical therapy for dry ...

The representation of women in medicine continues to increase, as 37% of U.S. physicians and 54% of medical students are ...

A new AI medical receptionist offers potential to reduce clinical workload and empathetically engage with patients, according ...

In this video, Sham Mailankody, MBBS, discusses results from the long-term follow-up of CARTITUDE-1 patients receiving ciltacabtagene autoleucel, or cilta-cel, for the treatment of relapsed or ...

In this video, Sham Mailankody, MBBS, highlights data from a study of carfilzomib, lenalidomide and dexamethasone, with or without daratumumab, for patients with newly diagnosed multiple myeloma.“Four ...

In this video, Shahzad Raza, MD, discusses safety and efficacy data from Nexicart-2, which studied the use of chimeric antigen receptor T-cell therapy in relapsed or refractory light chain amyloidosis ...

In this video, Shahzad Raza, MD, discusses teclistamab as a potential treatment for patients with relapsed or refractory systemic light chain amyloidosis.“Teclistamab has already been approved in ...